EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
36 hedge funds and large institutions have $50.1M invested in ESSA Pharma in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
-10
Holders Change %
-21.74%
% of All Funds
0.49%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
3
Increased
7
Reduced
10
Closed
12
Calls
$157K
Puts
–
Net Calls
+$157K
Net Calls Change
+$33K
Top Buyers
| 1 |
Two Sigma Advisers
New York
|
+$306K |
| 2 |
DAM
DLD Asset Management
New York
|
+$290K |
| 3 |
AC
Aldebaran Capital
Carmel,
Indiana
|
+$271K |
| 4 |
JPMorgan Chase & Co
New York
|
+$260K |
| 5 |
DCM
Deuterium Capital Management
Clearwater,
Florida
|
+$174K |
Top Sellers
| 1 |
RI
RTW Investments
New York
|
-$1.99M |
| 2 |
ACM
Altium Capital Management
New York
|
-$597K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$324K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$180K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$122K |
